Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) Infection [Phase 2]
Phase 2 trial evaluating safety and antiviral effect of ABT-450/ritonavir and ABT-530 with and without ribavirin in adults with genotype 3 h…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Ultrasound Method to Measure Fibrosis of the Liver in Children [NA]
Update on a pediatric ultrasound method to measure liver fibrosis; the trial was terminated and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection [Phase 2]
A Phase 2 clinical trial evaluating the combination of faldaprevir, ribavirin, and TD-6450 for hepatitis C virus infection has completed, re…
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV [NA]
The UCLA-sponsored trial evaluating prevention strategies for Hepatitis B among homeless individuals at risk for HBV, Hepatitis C, and HIV h…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis [Phase 3]
Phase 3 safety and efficacy study evaluating daclatasvir with sofosbuvir and ribavirin for 12 or 16 weeks in genotype 3 chronic hepatitis C …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers [Phase 2]
Phase 2 trial update evaluating antiviral and antifibrotic liver therapy for hepatitis C in drinkers and non-drinkers.
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Clinical Pharmacology Study of MP-424 [Phase 1]
Phase 1 clinical pharmacology study of MP-424 in chronic hepatitis C has been completed.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin
This clinical trial update discusses outcomes and resistance in a French cohort of chronic hepatitis C patients treated with protease inhibi…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE) [Phase 3]
Phase 3 trial evaluating pegylated interferon alfa-2a plus ribavirin for chronic hepatitis C in non-genotype 2/3 patients; the study complet…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: EDP-494-001: A Study of EDP-494 in Healthy Subjects and Hepatitis C Patients [Phase 1]
This clinical trial update reports on a Phase 1 study of EDP-494 in healthy subjects and Hepatitis C patients. The trial status is completed…
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants [Phase 2]
Phase 2 trial evaluating the efficacy and safety of the combination of Simeprevir and Daclatasvir in adults with chronic hepatitis C genotyp…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065) [Phase 3]
Phase 3 trial of Grazoprevir and Elbasvir combination for chronic hepatitis C genotypes 1, 4, and 6 completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: To Evaluate the Safety and Efficacy of Sofosbuvir and Ribavirin in Patients With HCV (Genotype 3) Related Decompensated Cirrhosis [NA]
A clinical trial evaluating the safety and efficacy of Sofosbuvir plus Ribavirin in patients with genotype 3 hepatitis C-related decompensat…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1 [Phase 3]
A Phase 3 trial evaluating alisporivir (Deb025) combined with boceprevir in African American patients with chronic hepatitis C genotype 1 wa…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1 [NA]
This clinical trial update reports a study designed to bridge active heroin users to hepatitis C treatment using buprenorphine. The trial st…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: HIV and HCV Intervention In Drug Treatment Settings - 1 [Phase 3]
Phase 3 trial update on HIV and Hepatitis C interventions in drug-treatment settings, focusing on behavior therapy; the study status is comp…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users [Phase 4]
Phase 4 clinical trial update investigating pegylated interferon for acute hepatitis C virus infection in injection drug users; the study st…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection [Phase 4]
This Clinical Trial Update reports results from a Phase 4 study evaluating liver transplantation for end-stage liver disease caused by chron…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1 [NA]
A completed clinical trial update evaluating prevention of depression in methadone-maintenance patients receiving hepatitis C treatment. The…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug Users [Phase 3]
Phase 3 clinical trial update evaluating a Hepatitis B vaccine model used for HIV vaccine trials in drug users; the study status is complete…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Efficacy and Safety of Combination Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Sofosbuvir + Pegylated Interferon + Ribavirin in Hepatitis C Virus Genotype 1, 4 or 6 Infection (MK-5172-077) [Phase 3]
Phase 3 trial comparing Grazoprevir/Elbasvir to Sofosbuvir+Pegylated Interferon+Ribavirin in Hepatitis C virus genotypes 1, 4, or 6; study c…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Study to Reduce Intravenous Exposures (STRIVE) [Phase 2, Phase 3]
The STRIVE study, a Phase 2/3 trial sponsored by the National Institute on Drug Abuse (NIDA) to reduce intravenous exposures, targets patien…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Primary Prevention Hepatocellular Carcinoma by Metformin [Phase 3]
Phase 3 trial evaluating metformin for primary prevention of hepatocellular carcinoma in people with chronic liver disease, including chroni…
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Participants With Chronic Genotype 1 HCV Who Participated in a Prior Gilead-Sponsored HCV Treatment Study [Phase 2]
Phase 2 trial update of Ledipasvir/Sofosbuvir fixed-dose combination with or without ribavirin in chronic genotype 1 HCV patients who had pr…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: A Study to Investigate the Pharmacokinetic Interactions Between Simeprevir and Ledipasvir in a Treatment Regimen Consisting of Simeprevir, Sofosbuvir, and Ledipasvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection [Phase 2]
Phase 2 study evaluating pharmacokinetic interactions among Simeprevir, Ledipasvir, and Sofosbuvir in treatment-naive chronic hepatitis C ge…